Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.
Tsukita Y, Fujino N, Miyauchi E, Saito R, Fujishima F, Itakura K, Kyogoku Y, Okutomo K, Yamada M, Okazaki T, Sugiura H, Inoue A, Okada Y, Ichinose M.
Tsukita Y, et al. Among authors: saito r.
Mol Cancer. 2019 Feb 11;18(1):24. doi: 10.1186/s12943-019-0953-y.
Mol Cancer. 2019.
PMID: 30744655
Free PMC article.